About FHH
History
Organizational structure
- Standing Committee
- Sub-Committee
Ex-Chairperson
Members List
Photos
Bulletin Board
Information
Notice
Short Communications
Adulterated Herbal Medicine
- Purpose
- Database
Herbs World Wide
Meetings
Standing Committee
International Symposium
Meeting Materials
Sub-Committee 1
Sub-Committee 2
Sub-Committee 3
FHH Previous Meeting
Projects
Pharmacopoeia
- Purpose
- Products
- Terminology
- Link
FHH Atlas
FHH RMPM
- Purpose
- Results
- Distribution
COVID-19
COVID-19
Link
Link
Sign In
About FHH
History
Organizational structure
Ex-Chairperson
Members List
Photos
History
History
Organizational structure
Ex-Chairperson
Members List
Photos
Meetings
게시물 검색폼
Keyword
ADR
Adulteration
Aflatoxin
Benzopyrene
CITES
Collaboration
DNA
Efficacy
GA(C)P
GMP
Guideline
Heavy metal
Microorganism
Pesticide
Pharmacopoeia
Processing
Quality
Reference substance
Regulation
Registration
Safety
Sulfur dioxide
Surveillance
Training
Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
[Total :
709
]
No.
Code
Title
Speaker
Country
358
FSbC2 18 (2015)
EuropeanPharmacopoeia 5.12.reference standards
Admin
357
FSbC2 17 (2015)
EMEA document; Guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin
Admin
356
FSbC2 16 (2015)
EMA document; Concept paper on non-pharmacopoeial reference standards for herbal substances, herbal preparations and herbal medicinal products.pdf
Admin
355
FSbC2 17 (2014)
FHH Subcommittee 2 meeting note
So-Young Park
Republic of Korea
354
FSbC2 15 (2015)
EMA document; Guideline on specifications test procedures and acceptance criteria for herbal
Admin
353
12th FSC 16 (2014)
Report of the 12th Standing Committee Meeting of the Forum for the Harmonization of Herbal Medicines
Singapore
Singapore
352
FSbC2 14 (2015)
The 2nd draft guideline on establishment and management of RMPM for FHH members
Admin
351
FSbC2 13 (2015)
FHH website 2nd upgrade plan for easy-access of adultrated herbal medicines information
So-young PARK
Republic of Korea
350
FSbC2 12 (2015)
Proposal for the co-existence of the reference drugs of China and the FHH RMPM
Takashi HAKAMATSUKA
Japan
37
38
39
40
41
42
43
44
45